
InCELLia is a Greek startup specializing in mechanistic modeling for applications in pharmaceutical manufacturing, ecology, and personalized in silico therapies. They leverage mathematical precision and advanced computational tools to decipher complex biological systems related to health. Their interdisciplinary team integrates mechanistic modeling, machine learning, and biological/clinical insights to deliver personalized, predictive solutions for healthcare professionals. Services include clinical decision support tools, enhanced biomarker discovery, and refined clinical trials using in silico methodologies, aiming to push the boundaries of systems medicine and translate biomedical data into patient-specific outcomes for personalized healthcare innovation. They are focused on solving problems related to modeling, data analysis, and simulation in medicine, particularly in cancer biology.

InCELLia is a Greek startup specializing in mechanistic modeling for applications in pharmaceutical manufacturing, ecology, and personalized in silico therapies. They leverage mathematical precision and advanced computational tools to decipher complex biological systems related to health. Their interdisciplinary team integrates mechanistic modeling, machine learning, and biological/clinical insights to deliver personalized, predictive solutions for healthcare professionals. Services include clinical decision support tools, enhanced biomarker discovery, and refined clinical trials using in silico methodologies, aiming to push the boundaries of systems medicine and translate biomedical data into patient-specific outcomes for personalized healthcare innovation. They are focused on solving problems related to modeling, data analysis, and simulation in medicine, particularly in cancer biology.